Jérémy H Raymond

7PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer geneticsMedical biochemistry - lipidsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2026
MICAL2 as a key effector of β-catenin signaling driving melanoma progression and therapeutic resistance.

|Jun 11, 2025
Targeting GRPR for sex hormone-dependent cancer after loss of E-cadherin.

Jérémy H Raymond, Zackie Aktary, Marie Pouteaux

|Oct 31, 2024
The Lipid Droplet Protein DHRS3 Is a Regulator of Melanoma Cell State.

Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthiphol

|Apr 08, 2024
The lipid droplet protein DHRS3 is a regulator of melanoma cell state.

Eleanor Johns, Yilun Ma, Pakavarin Louphrasitthipol

|Feb 15, 2022
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.

Jérémy H Raymond, Zackie Aktary, Lionel Larue

|Apr 03, 2021
Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.

Hussein Akil, Mercedes Quintana, Jérémy H Raymond

Pageof 2

Frequent Collaborators

5 joint publications

Véronique Delmas

3 joint publications

Lionel Larue

2 joint publications

Irwin Davidson

2 joint publications

Richard M White